G. Muzanye

Geographic Differences in Time to Culture Conversion in Liquid Media: Tuberculosis Trials Consortium Study 28. Culture Conversion Is Delayed in Africa

John L. Johnson, S. Dorman, L. Diem, 2011, PloS one.

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.

John L. Johnson, R. Chaisson, C. Daley, 2006, American journal of respiratory and critical care medicine.

Evaluation of Time to Detection of Mycobacterium tuberculosis in Broth Culture as a Determinant for End Points in Treatment Trials

John L. Johnson, A. W. Sturm, S. Goldberg, 2010, Journal of Clinical Microbiology.

Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis.

Elisa M. Tjon Kon Fat, S. H. Kaufmann, Mahavir Singh, 2022, Tuberculosis.

Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

John L. Johnson, A. Goodridge, P. Nahid, 2012, Tuberculosis.

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

Charles M Heilig, Dick Menzies, John L. Johnson, 2009, American journal of respiratory and critical care medicine.

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

Daniel E. Zak, D. Zak, G. Schoolnik, 2020, Scientific Reports.

A Phase II Study Of A Rifapentine-Containing Regimen For Intensive Phase Treatment Of Pulmonary Tuberculosis: Preliminary Results For Tuberculosis Trials Consortium Study 29

John L. Johnson, S. Dorman, S. Ray, 2011, ATS 2011.

Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis

Elisa M. Tjon Kon Fat, A. Crampin, H. Dockrell, 2018, Scientific Reports.

Impact of mouth rinsing before sputum collection on culture contamination.

H. Mayanja-Kizza, G. Muzanye, J. Johnson, 2009, African health sciences.